Matches in Nanopublications for { ?s ?p "[Thus, the presence of ESO Ab identifies a tumor subtype of HR? (HER2? or HER2?) primary BC with frequent ESO expression and, together with the assessment of antigen expression in the tumor, may be instrumental for the selection of patients for whom ESO-based immunotherapy may complement standard therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- assertion description "[Thus, the presence of ESO Ab identifies a tumor subtype of HR? (HER2? or HER2?) primary BC with frequent ESO expression and, together with the assessment of antigen expression in the tumor, may be instrumental for the selection of patients for whom ESO-based immunotherapy may complement standard therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Thus, the presence of ESO Ab identifies a tumor subtype of HR? (HER2? or HER2?) primary BC with frequent ESO expression and, together with the assessment of antigen expression in the tumor, may be instrumental for the selection of patients for whom ESO-based immunotherapy may complement standard therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.